Litigation Details for In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)
✉ Email this page to a colleague
In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-12-15 |
| Court | District Court, N.D. California | Date Terminated | |
| Cause | 15:15 Antitrust Litigation | Assigned To | Richard G. Seeborg |
| Jury Demand | Plaintiff | Referred To | Susan G. Van Keulen |
| Patents | 10,213,400; 6,011,020; 6,780,889; 7,262,219; 7,668,730; 7,765,106; 7,765,107; 7,851,506; 7,895,059; 8,008,003; 8,263,650; 8,324,275; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 8,859,619; 8,952,062; 9,050,302; 9,486,426; 9,539,330 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In re Xyrem (Sodium Oxybate) Antitrust Litigation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in In re Xyrem (Sodium Oxybate) Antitrust Litigation
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-08-13 | 138 | Order on Motion to Dismiss | 1, 5, 6, and 11). 20 …families of patents. 8 UHS ¶ 80. None of the patents claim the active…file new ‘follow-on’ patents, and then file a new lawsuit asserting those patents.” Opp’n …through March 2017—the Patent Trial and Appeal Board invalidated many Xyrem patents during … 24 “patent and antitrust policies are both relevant in determining the ‘scope of the patent | External link to document |
| 2021-01-14 | 21 | Joint Case Management Statement | . 10 25 U.S. Patent Nos. 6,472,431, 6,708,889, 7,262,219, 7,851,506, 8,263,650, 8,324,… 8 Patents”);10 (2) patents relating to safe methods of drug distribution (the “REMS Patents”);11 and… Formulation patents, REMS patents, and/or DDI patents; 17 10. Whether… Jazz manipulation of the patent system to acquire sham patents. Xyrem’s active ingredient, 2 …none of 3 Xyrem’s patents claim it. Instead, Jazz acquired multiple bogus patents claiming processes | External link to document |
| 2021-03-08 | 62 | Amended Complaint | 2016 Mar. 15, 2033 21 10,213,400 Jan. 12, 2018 Feb. 26, 2019 …the ’219 patent, the ’730 patent, the 15 ’106 patent, and the ’107 patent. 16 150. On October… Simply owning a patent does not entitle the patent owner to exclude others. Patents 15 are routinely…acquired patent is not patentably 2 distinct from the invention claimed in an earlier patent (and no…and ’062 patents). 14 139. The patents in the ’431 family also include two patents that claim | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
